Orchard Therapeutics plc.

Orchard Therapeutics plc. (Nasdaq: ORTX), relating to its proposed sale to Kyowa Kirin Co. Under the terms of the agreement, ORTX shareholders are expected to receive $16.00 and one CVR worth $1.00 in cash per American Depositary Share they own.

SP Plus Corp.

SP Plus Corp. (Nasdaq: SP), relating to its proposed sale to Metropolis Technologies, Inc. Under the terms of the agreement, SP shareholders will receive $54.00 in cash per share they own.

SomaLogic, Inc.

SomaLogic, Inc. (Nasdaq: SLGC), relating to its proposed sale to Standard BioTools Inc. Under the terms of the agreement, SLGC shareholders will receive 1.11 shares of Standard BioTools per share they own

Blue Apron Holdings, Inc.

Blue Apron Holdings, Inc. (Nasdaq: APRN), relating to its proposed sale to Wonder Group. Under the terms of the agreement, APRN shareholders are expected to receive $13.00 in cash per share they own.

Chico’s FAS, Inc.

Chico’s FAS, Inc. (NYSE: CHS), relating to its proposed sale to Sycamore Partners. Under the terms of the agreement, CHS shareholders will receive $7.60 in cash per share they own.

FNCB Bancorp, Inc.

FNCB Bancorp, Inc. (Nasdaq: FNCB), relating to its proposed sale to Peoples Financial Services Corp. Under the terms of the agreement, FNCB shareholders are expected to receive 0.1460 shares of Peoples per share they own.

Applied Molecular Transport Inc.

Applied Molecular Transport Inc. (Nasdaq: AMTI), relating to its proposed sale to Cyclo Therapeutics, Inc. Under the terms of the agreement, AMTI shareholders are expected to receive 0.174 shares of Cyclo per share they own.

Splunk Inc.

Splunk Inc. (Nasdaq: SPLK), relating to its proposed sale to Cisco Systems, Inc. Under the terms of the agreement, SPLK shareholders are expected to receive $157.00 in cash per share they own.

Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), relating to its proposed sale to Alfasigma S.p.A. Under the terms of the agreement, ICPT shareholders are expected to receive $19.00 in cash per share they own.

Cambridge Bancorp

Cambridge Bancorp (Nasdaq: CATC), relating to its proposed sale to Eastern Bankshares, Inc. Under the terms of the agreement, CATC shareholders will receive 4.956 shares of Eastern per share they own.